CITADEL ADVISORS LLC 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | CITADEL ADVISORS LLC | 1,027,956 6.000% | -3 (-0.00%) | Filing |
| 2023-11-06 4:34 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | CITADEL ADVISORS LLC | 1,027,959 6.000% | 1,027,959 (New Position) | Filing |